Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Cost of Goods Sold 2011-2025 | ZTS

Zoetis annual/quarterly cost of goods sold history and growth rate from 2011 to 2025. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
  • Zoetis cost of goods sold for the quarter ending March 31, 2025 was $622M, a 3.27% decline year-over-year.
  • Zoetis cost of goods sold for the twelve months ending March 31, 2025 was $2.698B, a 3.13% increase year-over-year.
  • Zoetis annual cost of goods sold for 2024 was $2.719B, a 6.17% increase from 2023.
  • Zoetis annual cost of goods sold for 2023 was $2.561B, a 4.36% increase from 2022.
  • Zoetis annual cost of goods sold for 2022 was $2.454B, a 6.56% increase from 2021.
  
Zoetis Annual Cost of Goods Sold
(Millions of US $)
2024 $2,719
2023 $2,561
2022 $2,454
2021 $2,303
2020 $2,057
2019 $1,992
2018 $1,911
2017 $1,775
2016 $1,666
2015 $1,738
2014 $1,717
2013 $1,669
2012 $1,563
2011 $1,652
2010 $1,444
Zoetis Quarterly Cost of Goods Sold
(Millions of US $)
2025-03-31 $622
2024-12-31 $707
2024-09-30 $701
2024-06-30 $668
2024-03-31 $643
2023-12-31 $728
2023-09-30 $638
2023-06-30 $607
2023-03-31 $588
2022-12-31 $653
2022-09-30 $607
2022-06-30 $625
2022-03-31 $569
2021-12-31 $600
2021-09-30 $586
2021-06-30 $568
2021-03-31 $549
2020-12-31 $601
2020-09-30 $546
2020-06-30 $451
2020-03-31 $459
2019-12-31 $530
2019-09-30 $479
2019-06-30 $465
2019-03-31 $518
2018-12-31 $544
2018-09-30 $473
2018-06-30 $447
2018-03-31 $447
2017-12-31 $457
2017-09-30 $435
2017-06-30 $440
2017-03-31 $443
2016-12-31 $468
2016-09-30 $410
2016-06-30 $399
2016-03-31 $389
2015-12-31 $496
2015-09-30 $421
2015-06-30 $427
2015-03-31 $394
2014-12-31 $491
2014-09-30 $434
2014-06-30 $413
2014-03-31 $379
2013-12-31 $466
2013-09-30 $385
2013-06-30 $416
2013-03-31 $402
2012-12-31 $433
2012-09-30 $359
2012-06-30 $378
2012-03-31 $393
2011-12-31
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $69.034B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $82.342B 30.89
Takeda Pharmaceutical (TAK) Japan $47.411B 9.43
Daiichi Sankyo, - (DSNKY) Japan $44.972B 23.05
BeOne Medicines - (ONC) Cayman Islands $27.694B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.360B 0.00
Merck (MKKGY) Germany $16.226B 11.89
Summit Therapeutics (SMMT) United States $14.972B 0.00
Shionogi (SGIOY) Japan $14.581B 14.61
United Therapeutics (UTHR) United States $13.159B 11.64
Neurocrine Biosciences (NBIX) United States $12.599B 43.16
Orion OYJ (ORINY) Finland $10.006B 27.06
IPSEN (IPSEY) France $9.836B 0.00
Corcept Therapeutics (CORT) United States $7.555B 61.41
Stevanato Group S.p.A (STVN) Italy $7.193B 43.98
Madrigal Pharmaceuticals (MDGL) United States $6.277B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $5.982B 0.00
Ionis Pharmaceuticals (IONS) United States $5.890B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $4.000B 0.00
Hypermarcas (HYPMY) Brazil $3.132B 20.60
Crinetics Pharmaceuticals (CRNX) United States $2.856B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.782B 9.75
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.489B 13.46
BioCryst Pharmaceuticals (BCRX) United States $2.084B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.077B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.043B 0.00
Indivior (INDV) United States $1.917B 8.13
Centessa Pharmaceuticals (CNTA) United Kingdom $1.693B 0.00
Endo (NDOI) United States $1.618B 0.00
ARS Pharmaceuticals (SPRY) United States $1.563B 0.00
Evotec AG (EVO) Germany $1.410B 0.00
Ocular Therapeutix (OCUL) United States $1.327B 0.00
Guardian Pharmacy Services (GRDN) United States $1.245B 0.00
Dyne Therapeutics (DYN) United States $1.225B 0.00
Harrow (HROW) United States $1.156B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.070B 21.41
Enliven Therapeutics (ELVN) United States $1.058B 0.00
Verve Therapeutics (VERV) United States $0.991B 0.00
Collegium Pharmaceutical (COLL) United States $0.951B 5.13
Akebia Therapeutics (AKBA) United States $0.935B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.902B 0.00
Ardelyx (ARDX) United States $0.864B 0.00
Cronos Group (CRON) Canada $0.737B 0.00
Xeris Biopharma Holdings (XERS) United States $0.716B 0.00
Elite Pharmaceuticals (ELTP) United States $0.716B 0.00
KalVista Pharmaceuticals (KALV) United States $0.612B 0.00
Xencor (XNCR) United States $0.595B 0.00
Relay Therapeutics (RLAY) United States $0.576B 0.00
Regulus Therapeutics (RGLS) United States $0.568B 0.00
USANA Health Sciences (USNA) United States $0.567B 12.32
Altimmune (ALT) United States $0.550B 0.00
Theravance Biopharma (TBPH) United States $0.531B 0.00
Bioventus (BVS) United States $0.528B 13.40
AleAnna (ANNA) United States $0.520B 0.00
Zevra Therapeutics (ZVRA) United States $0.496B 0.00
Siga Technologies (SIGA) United States $0.459B 9.58
Amylyx Pharmaceuticals (AMLX) United States $0.455B 0.00
Oruka Therapeutics (ORKA) United States $0.449B 0.00
Tourmaline Bio (TRML) United States $0.432B 0.00
Organogenesis (ORGO) United States $0.415B 0.00
Savara (SVRA) United States $0.358B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.346B 9.35
Aquestive Therapeutics (AQST) United States $0.338B 0.00
Liminatus Pharma (LIMN) United States $0.333B 0.00
Heron Therapeutics (HRTX) United States $0.305B 0.00
Nature's Sunshine Products (NATR) United States $0.270B 24.83
Tonix Pharmaceuticals Holding (TNXP) United States $0.253B 0.00
Esperion Therapeutics (ESPR) United States $0.218B 0.00
MediWound (MDWD) Israel $0.210B 0.00
Galectin Therapeutics (GALT) United States $0.208B 0.00
ProKidney (PROK) United States $0.204B 0.00
Profound Medical (PROF) Canada $0.203B 0.00
Nanobiotix S.A (NBTX) France $0.202B 0.00
OmniAb (OABI) United States $0.202B 0.00
Aldeyra Therapeutics (ALDX) United States $0.190B 0.00
4D Molecular Therapeutics (FDMT) United States $0.189B 0.00
Larimar Therapeutics (LRMR) United States $0.175B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.155B 0.00
Aclaris Therapeutics (ACRS) United States $0.154B 0.00
Journey Medical (DERM) United States $0.148B 0.00
Innate Pharma SA (IPHYF) France $0.145B 0.00
Lyell Immunopharma (LYEL) United States $0.142B 0.00
Lexeo Therapeutics (LXEO) United States $0.141B 0.00
VAXART, INC (VXRT) United States $0.140B 0.00
Avita Medical (RCEL) United States $0.139B 0.00
Inhibikase Therapeutics (IKT) United States $0.126B 0.00
Korro Bio (KRRO) United States $0.117B 0.00
Champions Oncology (CSBR) United States $0.116B 19.09
Protara Therapeutics (TARA) United States $0.115B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.113B 0.00
Cardiol Therapeutics (CRDL) Canada $0.109B 0.00
Achieve Life Sciences (ACHV) Canada $0.109B 0.00
Nektar Therapeutics (NKTR) United States $0.107B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.102B 0.00
Cassava Sciences (SAVA) United States $0.100B 0.00
Fractyl Health (GUTS) United States $0.094B 0.00
Dominari Holdings (DOMH) United States $0.092B 0.00
Wellgistics Health (WGRX) United States $0.088B 0.00
Nutriband (NTRB) United States $0.087B 0.00
Surrozen (SRZN) United States $0.085B 0.00
Unicycive Therapeutics (UNCY) United States $0.084B 0.00
Arch Biopartners (ACHFF) Canada $0.084B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.080B 59.56
ESSA Pharma (EPIX) Canada $0.075B 0.00
Inotiv (NOTV) United States $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.071B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
NRx Pharmaceuticals (NRXP) United States $0.056B 0.00
Metagenomi (MGX) United States $0.055B 0.00
Rafael Holdings (RFL) United States $0.055B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
Telomir Pharmaceuticals (TELO) United States $0.052B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Context Therapeutics (CNTX) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.051B 0.00
Klotho Neurosciences (KLTO) United States $0.049B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Jupiter Neurosciences (JUNS) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.034B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.032B 0.00
China SXT Pharmaceuticals (SXTC) China $0.030B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Relmada Therapeutics (RLMD) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Carisma Therapeutics (CARM) United States $0.021B 0.00
FibroGen (FGEN) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Ernexa Therapeutics (ERNA) United States $0.019B 0.00
Lipocine (LPCN) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
Mannatech (MTEX) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.21
TherapeuticsMD (TXMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Ainos (AIMD) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Citius Pharmaceuticals (CTXR) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
SHINECO (SISI) China $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Plus Therapeutics (PSTV) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00